139 related articles for article (PubMed ID: 7990943)
21. Drug price deal spells windfall for researchers.
Bosch X
Nature; 2001 Nov; 414(6860):138. PubMed ID: 11700514
[No Abstract] [Full Text] [Related]
22. Is the DOTS strategy sufficient to achieve tuberculosis control in low- and middle-income countries? 1. Need for interventions in universities and medical schools.
Caminero JA
Int J Tuberc Lung Dis; 2003 Jun; 7(6):509-15. PubMed ID: 12797691
[TBL] [Abstract][Full Text] [Related]
23. University-industry collaboration. Last of the big-time spenders?
Lawler A
Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
[No Abstract] [Full Text] [Related]
24. The destruction of medicine by market forces: teaching acquiescence or resistance and change?
Wolfe SM
Acad Med; 2002 Jan; 77(1):5-7. PubMed ID: 11788316
[No Abstract] [Full Text] [Related]
25. [Advice for the shared project study of the medical discipline project].
Visser HK
Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1043-4. PubMed ID: 3724894
[No Abstract] [Full Text] [Related]
26. Back from the brink.
Nature; 2001 Jul; 412(6845):361. PubMed ID: 11473267
[No Abstract] [Full Text] [Related]
27. The Utah primary care experience.
Krugman RD
Ann Fam Med; 2006; 4 Suppl 1(Suppl 1):S19-21; discussion S58-60. PubMed ID: 17003156
[No Abstract] [Full Text] [Related]
28. [University as business investment. Money from trade and industry more and more important for Swedish medical research].
Lakartidningen; 2003 Apr; 100(15):1309-12. PubMed ID: 12739398
[No Abstract] [Full Text] [Related]
29. Dundee: discovering life sciences.
Tasker H
Drug Discov Today; 2006 May; 11(9-10):379-82. PubMed ID: 16635798
[No Abstract] [Full Text] [Related]
30. US medical schools should say no to pharma support.
Tanne JH
BMJ; 2008 May; 336(7652):1035. PubMed ID: 18467393
[No Abstract] [Full Text] [Related]
31. NIH budget. Boom and bust.
Couzin J; Miller G
Science; 2007 Apr; 316(5823):356-61. PubMed ID: 17446363
[No Abstract] [Full Text] [Related]
32. Funding for medicine at UMC would benefit all Missourians.
Crist WM; Hugh E; Stephenson SD
Mo Med; 2006; 103(2):138. PubMed ID: 16703711
[No Abstract] [Full Text] [Related]
33. Dreaming big dreams: the University of Alabama at Birmingham School of Medicine.
Mansfield LA
South Med J; 2003 Aug; 96(8):764-6, table of contents. PubMed ID: 14515915
[TBL] [Abstract][Full Text] [Related]
34. Industry and the university.
Haber E
Nat Biotechnol; 1996 Apr; 14(4):441-2. PubMed ID: 9630917
[No Abstract] [Full Text] [Related]
35. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
36. The effects of federal agency matching fund and cost-sharing policies on research universities and medical colleges.
Feller I
Acad Med; 1997 Dec; 72(12):1086-7. PubMed ID: 9435715
[No Abstract] [Full Text] [Related]
37. Universities seek to boost industry partnerships.
Hayden EC
Nature; 2014 May; 509(7499):146. PubMed ID: 24805325
[No Abstract] [Full Text] [Related]
38. German states wield the axe.
Schiermeier Q
Nature; 2010 Jun; 465(7301):996. PubMed ID: 20577180
[No Abstract] [Full Text] [Related]
39. Syngenta ends plant-research deal with Berkeley.
Dalton R
Nature; 2003 Nov; 426(6964):216. PubMed ID: 14628007
[No Abstract] [Full Text] [Related]
40. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?].
Cohen AF
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1438-42. PubMed ID: 11503309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
